The Reg Gamma-Proteasome Forms A Regulatory Circuit With I Kappa B Epsilon And Nf Kappa B In Experimental Colitis
Jinjin Xu,Lei Zhou,Lei Ji,Fengyuan Chen,Karen Fortmann,Kun Zhang,Qingwu Liu,Ke Li,Weicang Wang,Hao Wang,Wei Xie,Qingwei Wang,Jiang Liu,Biao Zheng,Pei Zhang,Shixia Huang,Tieliu Shi,Biaohong Zhang,Yongyan Dang,Jiwu Chen,Bert W. O'Malley,Robb E. Moses,Ping Wang,Lei Li,Jianru Xiao,Alexander Hoffmann,Xiaotao Li
DOI: https://doi.org/10.1038/ncomms10761
IF: 16.6
2016-01-01
Nature Communications
Abstract:Increasing incidence of inflammatory bowel disorders demands a better understanding of the molecular mechanisms underlying its multifactorial aetiology. Here we demonstrate that mice deficient for REG gamma, a proteasome activator, show significantly attenuated intestinal inflammation and colitis-associated cancer in dextran sodium sulfate model. Bone marrow transplantation experiments suggest that REG gamma's function in non-haematopoietic cells primarily contributes to the phenotype. Elevated expression of REG gamma exacerbates local inflammation and promotes a reciprocal regulatory loop with NF kappa B involving ubiquitin-independent degradation of I kappa B epsilon. Additional deletion of I kappa B epsilon restored colitis phenotypes and inflammatory gene expression in REG gamma-deficient mice. In sum, this study identifies REG gamma-mediated control of I kappa B epsilon as a molecular mechanism that contributes to NF kappa B activation and promotes bowel inflammation and associated tumour formation in response to chronic injury.